← rohini singh
what i talk about
The Age of AI in Pharma
On why AI's integration into healthcare and drug discovery feels different from every other industry it has touched
Open Weights, Closed Borders
On open source, the U.S. - China model race, and who gets to govern openness
The Speed of Discovery
On startups doing cool things in pharma
Using LLMs to Classify FDA Adverse Event Reports